Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by SizzlinSteakson Sep 04, 2018 8:39am

140 Views

Post# 28557758

RE:The manipulation in the Venture exchange....

Yup you are 100% right. The manipulators are very real. There are entities that do not want these small companies to succeed and do not want retail to make any money. The venture particularly is a very dismal place to invest.

YanTheDon wrote: is astonishing.
I feel like there are people specifically hired to make sure most of us don't make money.
BAD NR = Massive drop
Not so bad NR = Massive drop
Good NR = Stays at the same level or barely moves
Random days = SPIKE IN SP.